Medication use for epilepsy prevention after stroke
What evidence is needed?
More primary research is needed.
What evidence is available?
Reliable systematic reviews that show evidence gaps:
Chang RS, Leung WC, Vassallo M, Sykes L, Battersby Wood E, Kwan J. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke. Cochrane Database Syst Rev. 2022;2(2):CD005398. More about the review
Reliable, but not updated, systematic reviews that show evidence gaps:
None identified
Information from SBU Enquiry Service: SBU. Läkemedelsbehandling för att förebygga epilepsi efter stroke eller traumatisk hjärnskada [Medication use for epilepsy prevention after stroke or traumatic brain injury]. Stockholm: Statens beredning för medicinsk och social utvärdering (SBU); 2024. SBU:s upplysningstjänst. More about the report
- Registration number:
- Published:
![](/static/images/pusselbit.jpg)
Evidence gap identifies methods or practices for which no conclusive systematic review of benefits and harms has been published. Gaps in scientific evidence appear on the SBU website to help researchers and granting agencies identify areas that are in need of research or systematic review. An additional objective is to offer healthcare and social service providers a basis for setting priorities.